You just read:

Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease

News provided by

Amicus Therapeutics

Dec 08, 2010, 09:00 EST